SCHEMBL3983704

SCHEMBL3983704

CN1CCn2c(c(OCc3ccccc3)c3c(=O)n(Cc4ccc(F)c(Cl)c4)nc(-n4ccccc4=O)c32)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 1/20 0.36
KLKB1 P03952 2/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 2/20 0.33
PTGER4 P35408 1/20 0.33
GRM2 Q14416 2/20 0.33
FSCN1 Q16658 1/20 0.33
DRD4 P21917 1/20 0.32
FAAH O00519 1/20 0.31
MGLL Q99685 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MCHR1 Q99705 2/20 0.31
KDM5A P29375 1/20 0.31
KDM5B Q9UGL1 1/20 0.31
P2RX7 Q99572 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
F10 P00742 1/20 0.31
PTGDR2 Q9Y5Y4 1/20 0.31
ALOX5AP P20292 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3985345 0.87 SCD (0.37) SCDPTGER4GRM2FSCN1DRD4
SCHEMBL13842777 0.87 PTGER4 (0.35) KLKB1PTGER4GRM2FSCN1P2RX7
SCHEMBL3985667 0.86 SCD (0.39) SCDMEN1ALDH1A1KMT2APTGER4
SCHEMBL3987007 0.85 SCD (0.38) SCDMEN1ALDH1A1KMT2APTGER4
SCHEMBL3983623 0.82 SCD (0.38) SCDMEN1ALDH1A1KMT2APTGER4
SCHEMBL3985359 0.81 SCD (0.33) SCDDRD4
SCHEMBL4746270 0.79 SCD (0.40) SCDMEN1ALDH1A1KMT2AFSCN1
SCHEMBL3981450 0.78 SMN1; SMN2 (0.43) MEN1ALDH1A1KMT2AFAAHMGLL
SCHEMBL4750000 0.77 FSCN1 (0.43) SCDFSCN1DRD4NPSR1SMN1; SMN2
SCHEMBL3987185 0.77 SMN1; SMN2 (0.40) ALDH1A1GRM2FAAHMGLLNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756114-B1 HIV INTEGRASE INHIBITORS MERCK SHARP & DOHME (US) 2014-11-19 EP disclosed
US-7538112-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-05-26 US disclosed
US-20080287394-A1 Hiv Integrase Inhibitors MERCK & CO., INC. (US) 2008-11-20 US disclosed
EP-1756114-A2 HIV INTEGRASE INHIBITORS Merck and Co., Inc. (US) 2007-02-28 EP disclosed
WO-2005110414-A2 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2005-11-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287394-A1 Hiv Integrase Inhibitors DHPS, DPYD, TYMP SCD 2672/4885KLKB1 3445/4885MEN1 4592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.